Zecon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zecon

Quick Facts

Property Description
Active ingredient Fluconazole
Form Tablet, capsule, oral suspension, intravenous solution
Pharmacological class Systemic Antifungal Agent
Common use (General) Management of fungal and yeast infections
Origin Synthetic

What Pharmacological Class Does it Belong To?

Zecon is a prescription-only drug whose active substance, Fluconazole, is classified as a systemic antifungal agent and belongs specifically to the triazole subclass of azole antifungals. This classification means the medication is intended to be absorbed into the bloodstream to target fungal organisms throughout the body's tissues. Fluconazole is a synthetic compound, chemically manufactured, and pharmacological studies have consistently shown it exhibits high selectivity for fungal enzymes, a feature clinically recognized within the triazole class.

Composition and Available Forms

The core composition of Zecon relies exclusively on Fluconazole, the sole compound responsible for the therapeutic effect, distinguishing it as a single-ingredient product. The active substance is manufactured into several preparations to accommodate various patient needs and administration settings. These forms include solid oral doses, such as the tablet and capsule, a palatable oral suspension, and a sterile solution suitable for delivery via the intravenous route. This range of forms provides clinical flexibility, supporting both oral and direct systemic administration.

General Purpose of This Medicine

The general purpose of this medication is to control and inhibit the proliferation of infections caused by various types of pathogenic fungi and yeasts. Zecon's primary action is fungistatic, meaning it works by halting the organism's growth and reproduction rather than immediately destroying it. This mechanism involves selectively inhibiting the process a fungus needs to synthesize ergosterol, a crucial structural component required to maintain its cell membrane integrity. This fundamental action is key to containing the spread of established fungal infections systemically.

Regulatory References

  1. Fluconazole: MedlinePlus Drug Information

What side effects are possible with Zecon?

Possible side effects and safety information

The officially documented safety profile of Zecon (Fluconazole) is classified by regulatory authorities (such as the FDA and EMA) into frequency tiers and System-Organ-Classes (SOC).


Frequency-Classified Adverse Reactions

The majority of documented reactions fall into the Common frequency category. These often involve the Gastrointestinal Disorders system, including nausea, vomiting, diarrhoea, and abdominal pain. Other common events include headache and temporary elevations in liver enzyme values (ALT, AST, and Alkaline phosphatase). Effects classified as Uncommon include dizziness, seizures, and hypokalaemia.

Serious Adverse Reactions and Restrictions

Regulatory documents emphasize the risk of rare but serious adverse reactions, which include severe hepatic events such as hepatic failure and potentially life-threatening skin conditions like Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The safety profile also notes rare cardiac risks, specifically QT prolongation which may lead to Torsade de pointes.

Use of this medicine is contraindicated in individuals with a known hypersensitivity to azole antifungals. It is also restricted from concomitant use with certain medications known to prolong the QTc interval, due to the cardiac risk. Specific safety considerations are required for patients with pre-existing renal impairment or hepatic dysfunction.

Overdose and Emergency Response

Documented Overdose Manifestations

The official regulatory documentation on Zecon (Fluconazole) overdose strictly details the reported clinical manifestations and the required emergency actions for overexposure. Overexposure has been formally reported to result in specific, serious Central Nervous System (CNS) effects. These documented signs and symptoms include hallucination and paranoid behavior. The presence of these acute psychiatric presentations necessitates immediate professional medical assessment and intervention.


Required Emergency Actions and Management

In the event of a suspected overdose, urgent medical attention must be sought immediately. Regulatory documents mandate that symptomatic treatment and supportive measures should be instituted without delay to manage the clinical presentation.

There is no specific pharmacological antidote described for Fluconazole overdose. Management procedures focus on reducing the active substance concentration. If clinically indicated, gastric lavage may be instituted. Furthermore, the drug is largely excreted through the urine; therefore, hemodialysis can be utilized as a documented procedure, as a three-hour session is known to reduce plasma levels by approximately 50%. This procedure is a specific consideration related to the drug's primary route of renal excretion and elimination.

Therapeutic Uses of Zecon

Zecon is a prescription medication containing fluconazole, an antifungal agent relevant for easing conditions presenting with systemic or localized discomfort.

The indications for Zecon include use across therapeutic domains involving certain distressing symptoms caused by fungal overgrowth. This includes symptom clusters that may become intense or disruptive, such as vaginal candidiasis (yeast infections), oropharyngeal and esophageal candidiasis (thrush), and conditions linked to organ-specific functional stress, such as cryptococcal meningitis.

Zecon is applied in addressing symptoms that interfere with daily comfort. It is commonly used in clinical settings that involve acute or unstable symptom patterns. It also plays a role in managing candidiasis in high-risk patients, such as those facing heightened systemic burden, and is commonly used to help with easing the overall symptom load during periods of heightened discomfort. It supports general well-being during symptomatic phases by providing symptomatic assistance against fungal infections.


Quick Fact: Focus on Fungal Overgrowth

Eligibility and Restrictions for Use

Who can and cannot use Zecon?


The eligibility for using Zecon (fluconazole) is strictly defined by regulatory authorities based on pre-existing conditions and patient demographics.

Contraindicated Populations

Use is strictly prohibited (contraindicated) for patients who have a known allergy or hypersensitivity to fluconazole, related azole antifungal agents, or any of the product’s components. It is also contraindicated for patients concurrently taking specific medications known to prolong the QT interval and metabolized by the CYP3A4 enzyme (e.g., cisapride, pimozide).


Conditional and Restricted Use

Eligibility is conditional on a patient’s organ function. Patients with impaired renal function require a dose adjustment for multiple-dose regimens, and those with liver dysfunction must be monitored closely due to the potential for serious hepatic events. Caution is also required for patients with pre-existing cardiac risk factors or electrolyte abnormalities.


Age and Reproductive Status

Zecon is generally established for use in most ages (typically mathbfge 6 months for many indications), but it is not recommended for the indication of vaginal candidiasis in children under 16 or in older adults. For pregnant women, chronic, high-dose use is not recommended during the first trimester. While a single low dose may be deemed acceptable, breastfeeding mothers are advised against using repeated or high-dose regimens.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Zecon (Fluconazole) is primarily defined by its officially documented ability to inhibit certain cytochrome P450 (CYP) enzymes, specifically being a potent inhibitor of CYP2C9 and a moderate inhibitor of CYP2C19 and CYP3A4. This metabolic inhibition reduces the clearance of co-administered medicines that are metabolized by these enzymes, potentially leading to increased plasma concentrations and toxicity.


Formally Contraindicated Combinations

Official regulatory labeling dictates that co-administration with the following medicines is contraindicated due to the high risk of serious cardiac events (e.g., QTc prolongation) resulting from elevated exposure:

  • Cisapride, Astemizole, Pimozide, Quinidine, and Erythromycin
  • Terfenadine (when Zecon dose is 400 mg/day or higher)

Interactions Requiring Caution and Monitoring

Many other interactions are officially documented as requiring caution due to exposure modification. For example, co-administration with Warfarin may increase prothrombin time, while Cyclosporine and Tacrolimus plasma levels are significantly increased. Conversely, a co-administered medicine like Rifampin is documented to reduce Zecon's plasma concentration.

The regulatory labeling confirms that food does not affect the absorption of Zecon, allowing administration without regard to meals.

Mechanism of Action

Targeting the Fungal Cell's Foundation

Zecon mediates its action by specifically targeting a single enzyme, lanosterol 14 alpha-demethylase, which is central to the biosynthesis of the fungal organism's key membrane components. This interaction type is an inhibition of the enzyme.


Disruption of the Ergosterol Biosynthesis Pathway

The inhibition blocks the crucial molecular cascade responsible for creating ergosterol, the primary sterol component of the fungal cell membrane. Blocking this pathway hinders the incorporation of ergosterol into the fungal membrane structure, simultaneously promoting the accumulation of toxic methylsterols, thereby reducing the membrane's structural stability.


Resulting Physiological Event: Cell Integrity Failure

The failure to create a stable cell membrane leads to a compromise of cellular integrity and increased permeability, which promotes the leakage of the cell's internal contents. This event reflects the mechanism's action on fungal cell viability and is the basis of the drug's activity.

Dosage and Administration Information

Zecon, which contains the active substance fluconazole, is administered through either the oral route (via tablets, capsules, or an oral suspension) or the intravenous (IV) route. The specific route is chosen based on the clinical setting and the patient's condition, though the dose remains the same for both oral and IV administration due to the high oral bioavailability.

The majority of treatment regimens follow a once-daily schedule, although patterns vary significantly by indication. For certain systemic or severe infections, therapy often begins with a loading dose on Day 1, which may be up to twice the regular daily maintenance dose of 100 mg to 400 mg. Conversely, uncomplicated conditions, such as vaginal candidiasis, are treated with a single, 150 mg dose.

Administration Conditions and Adjustments

Feature Official Usage Principle
Timing in relation to food Oral doses may be taken with or without food.
Preparation The oral suspension must be shaken well before use. The IV solution is infused slowly, with a rate not exceeding 200 mg per hour.
Renal Impairment A dosage reduction of 50% of the standard daily dose is necessary for patients with creatinine clearance leq 50 mL/ min, with the full dose administered after each dialysis session.
Duration of Use Treatment duration ranges widely, from a single day for acute cases to long-term (e.g., 6–12 months or longer) suppressive therapy for cryptococcal disease relapse prevention.

The pediatric dosing schedule is calculated on a weight-based (mg/kg) system, while older adults use the standard dose unless kidney function requires adjustment. In case a dose is missed, it is typically taken as soon as remembered, unless it is near the next scheduled dose, in which case the missed dose should be skipped, and the original schedule resumed.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zecon

This section describes the types of clinical studies and research findings that governmental regulators and scientific bodies rely on to understand Zecon (Fluconazole). This information is a summary of the evidence landscape and should not be used as clinical advice.

Evidence for Fungal Infections of the Mouth and Esophagus

Research examining Zecon for Oropharyngeal and Esophageal Candidiasis (thrush) primarily involves Randomized Controlled Trials (RCTs), exploring conditions where symptoms may vary in intensity. Studies monitored outcomes related to physical discomfort and systemic imbalance, tracking how often clinical clearance or healing was observed. Findings describe some patterns observed in these studies across adult and pediatric populations.

However, data for certain groups remain insufficient, and the research provides limited insight into long-term patterns of recurrence or management of chronic vaginal candidiasis. Research is ongoing to further investigate the impact of potential azole-non-susceptible fungal strains.

Evidence for Systemic and Bloodstream Infections

For more severe conditions, such as Invasive or Systemic Candidiasis, the evidence base includes large-scale RCTs and extensive observational cohort studies. Studies explored outcomes related to physiological strain in critically ill patients. Researchers tracked outcomes, including the rate of microbiological clearance and overall mortality rates. Comparative evidence is lacking for certain non--albicans strains like C. glabrata, and the long-term effects are not fully established.

Evidence for Meningitis and Prophylactic Use

Zecon was studied for its use in the consolidation and maintenance phases of therapy for Cryptococcal Meningitis in immunocompromised patients, focusing on CSF culture status. Separately, research has explored Fungal Prophylaxis (prevention) in very specific, high-risk groups, such as very low birth weight (VLBW) infants and transplant recipients, monitoring the incidence of invasive fungal infection (IFI).

Gaps and Uncertainty in the Research Record

Research highlights several areas where more information is needed. Data for certain groups remain insufficient, and subgroup findings are uncertain. Research is ongoing to address concerns regarding the development of fungal resistance to azoles that may be associated with widespread use in prophylactic settings. Study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Fluconazole vs amphotericin B for the treatment of candidemia in patients without neutropenia: a systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Zecon (FAQ)

Q: How quickly does Zecon start working after the first time you take it?

Studies on Zecon for certain acute fungal conditions, such as vaginal candidiasis, indicate that the median time until patients report the onset of symptom relief is generally about one day after taking a single dose. Official product information describes that the time until a measurable response is observed may vary depending on the condition being addressed.

Q: Are there any common foods or drinks to avoid while taking Zecon?

Official information indicates that taking Zecon with or without food does not affect its absorption. However, combining Zecon with alcohol is associated with an increased risk of elevated liver enzyme values, which can also be associated with side effects such as dizziness and nausea.

Q: Can Zecon make you feel tired or drowsy during the day?

Regulatory documents list side effects that may affect alertness. Dizziness and headache are noted as common reactions. Some official reports also list somnolence (drowsiness) and general fatigue as possible but less frequent effects.

Q: Is Zecon considered safe for older people?

Use in older adults is generally supported by clinical data, but official guidance advises caution. Older patients are more likely to have reduced kidney function, which requires a careful dose adjustment based on the official clearance guidelines. When dose adjustments are determined based on kidney function, the medication is generally managed according to standard protocols.

Q: What is the longest time a person can safely take Zecon?

Treatment duration varies greatly, from a single dose for acute cases to long-term suppressive therapy that may last six months to a year or more. For any extended use, the regulatory guidance stresses the need for frequent monitoring of both kidney and liver function as a measure described in official documents to manage potential risks.

Q: I heard Zecon is a 'new' drug—how long has it been available?

The active substance in Zecon, fluconazole, is not considered a new medication. It was first approved by the United States Food and Drug Administration (FDA) and has been available for prescription use since 1990.

Q: Can Zecon affect my sleep schedule or patterns?

Official documentation does not consistently list specific sleep disturbances or insomnia as common side effects. However, rare effects on the nervous system, such as seizures or somnolence (drowsiness), have been reported, which could indirectly affect sleep.

Q: Are there any special warnings about driving while taking Zecon?

Official warnings advise that patients should be aware of the potential for occasional dizziness or seizures while taking this medication. Official labeling states that the possibility of these events should be taken into account when operating machinery or driving.

Q: What if I take Zecon and then decide to stop it?

For multi-dose or long-term treatments, official product information describes that continuation of therapy until the fungal infection has subsided is generally required. Stopping the medicine too soon may be associated with the recurrence of the active infection.

Q: Does Zecon interact with birth control pills?

Official regulatory sources generally indicate that Zecon is not likely to significantly affect hormonal contraception. However, as with any medicine, patients should be aware of potential issues like unusual bleeding patterns or if they experience severe vomiting or diarrhea.

Q: Are there any known interactions between Zecon and herbal supplements?

Specific interaction data for many herbal supplements is not typically included in the official product documents. Due to Zecon's strong inhibition of CYP enzymes, Official guidance often highlights the importance of patient communication regarding all concomitant products due to the drug’s potential to affect metabolism.

Q: Can I drink alcohol while taking Zecon?

Official warnings do not prohibit alcohol use but recommend caution. Both Zecon and alcohol can put stress on the liver and can cause symptoms like nausea or dizziness. Combining them may increase the overall risk of these side effects.

Q: Does Zecon affect blood pressure?

Zecon is known to interact with certain blood pressure medications by increasing their concentration in the body. While direct, common effects on blood pressure are not prominently listed as a side effect, the drug does carry a rare risk of affecting heart rhythm (known as QT prolongation).

Q: Do I need any special monitoring or tests while taking Zecon?

Official regulatory guidance describes that monitoring is necessary. Regular testing of both liver function (through blood tests) and kidney function (creatinine clearance) is described as required, especially for patients with pre-existing dysfunction or those on long-term treatment.

Q: What happens if I take Zecon too close to bedtime?

The recommended schedule for the medicine is generally a once-daily schedule. While there is flexibility, taking Zecon at the same general time each day is advised to ensure a consistent concentration of the medicine in the body. The timing relative to bedtime does not usually have specific warnings in the product information.

Q: Is it true that Zecon needs to be taken at the exact same time every day?

It is generally recommended to take Zecon around the same time each day to help maintain consistent blood levels. Achieving this consistency is indicated as important for the drug's effectiveness, though following a regular once-daily schedule is typically sufficient.

Q: Is Zecon linked to any mood changes or irritability?

Official regulatory reports indicate that mood changes or related effects are rare and are an incidence not consistently known. Mental status changes, such as fearfulness or suspiciousness, have primarily been noted in cases of overdose.

How should Zecon be stored and disposed of?

The storage and disposal of Zecon (Fluconazole) must strictly follow official regulatory requirements.

Formulation Required Storage Condition
Tablets, Capsules, Dry Powder Store below 30 C (86 F) and away from excess heat and moisture.
Reconstituted Suspension Store between 5 C and 30 C (41 F and 86 F). Do not freeze.

The reconstituted oral suspension is stable for 14 days and any unused portion must be discarded after this time. All medication must be kept in its tightly closed original container and stored in a secure location, out of the sight and reach of children. Unused or expired Fluconazole must be thrown away according to local guidelines, such as drug take-back programs, and must not be flushed down a toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zecon found in:

A-Z Index: